This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter          

Search results for "" (5834)

Biologic add-on therapy effective for severe asthma in real-world study
Lebrikizumab and topical steroids effective in moderate to severe atopic eczema
Gestational age estimation more accurate with AI compared to standard biometry
Is heart failure risk increased following COVID-19 infection?
Can procalcitonin levels determine which patients will benefit from azithromycin in lower RI? 
Diagnostic aid quickly and reliably identifies respiratory pathogens in critically ill children
Talquetamab effective in relapsed/refractory multiple myeloma
Skeletal muscle reduces nearly 2% per day upon admission to intensive care
Anti-CD20 therapy increases complication risk in COVID-19 for blood cancer patients
Remdesivir treatment improves biomarkers associated with severe COVID-19
Combining respiratory SOFA and burn area score predict mortality in severe burn and inhalation injury
Screening-based predictive tools for COVID-19 in ED inferior to PCR test
Brain-derived tau an important biomarker for Alzheimer’s disease
Early emollient use among high-risk infants prevents atopic eczema
Fidanacogene elaparvovec gene therapy effective for haemophilia B
Molnupiravir treatment fails to reduce adverse outcomes among high-risk vaccinated patients
Favipiravir shortens recovery time only for younger hospitalised COVID-19 patients
Only some post COVID-19 condition symptoms specific to the virus
Coronary artery calcium score and cystatin C level combined predict MACCE in chest pain
Herpes zoster infection linked to higher risk of stroke and coronary heart disease
Glofitamab fast and effective in refractory mantle cell lymphoma
Higher lipoprotein A in hypertensives increases risk of adverse cardiovascular events
Drinking coffee and tea significantly reduces cardiovascular disease mortality
Meet the Expert: Philip Mease on psoriatic arthritis
Vaccination found to reduce risk of post-COVID-19 condition
CHMP recommends Enhertu for HER2-low breast cancer treatment
Significant placebo response to pain in cannabinoid clinical trials